Kolexia
Thobois Stephane
Neurologie
Hôpital Pierre Wertheimer
Bron, France
237 Activités
3 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Maladie de Parkinson Syndromes parkinsoniens Dystonie Dyskinésies Ataxie Troubles dystoniques Troubles de la motricité Tremblement Syndrome de Tourette

Industries

Boston Scientific
11 collaboration(s)
Dernière en 2023
Merz
10 collaboration(s)
Dernière en 2023
Abbvie
7 collaboration(s)
Dernière en 2023
Aguettant
5 collaboration(s)
Dernière en 2023

Dernières activités

LUMA: A Phase 2b, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Determine the Efficacy and Safety of BIIB122 in Participants With Parkinson's Disease
Essai Clinique (Biogen)   15 mars 2024
The impact of subthalamic deep-brain stimulation in restoring motor symmetry in Parkinson's disease patients: a prospective study.
Journal of neurology   09 février 2024
PERSO-PERF: Could Psycho-bio-social Context and Personality be a Predictive Factor of Quality of Life Amelioration After Continuous Subcutaneous Apomorphine Infusion in Parkinson's Disease Patients? - PERSO-PERF Study
Essai Clinique (CHU Toulouse)   30 janvier 2024
Clinical and genetic keys to cerebellar ataxia due to FGF14 GAA expansions.
EBioMedicine   26 décembre 2023
PSP-Richardson's Syndrome as a Rare Phenotypic Expression of Very Late-Onset Huntington's Disease: A Case Report.
Movement disorders clinical practice   21 décembre 2023
Imbalanced motivated behaviors according to motor sign asymmetry in drug-naïve Parkinson's disease.
Scientific reports   01 décembre 2023
ARITEP: Involvement of the Serotonergic System in the Control of Impulsivity in Tourette Disorder.
Essai Clinique (Hospices Civils de Lyon)   22 novembre 2023
Guillain-Barré syndrome following subthalamic nucleus - Deep Brain Stimulation in Parkinson's disease: A case report.
Revue neurologique   23 octobre 2023
Motivational and cognitive predictors of apathy after subthalamic nucleus stimulation in Parkinson's disease.
Brain : a journal of neurology   03 octobre 2023
Noradrenergic alterations in Parkinson's disease: a combined 11C-yohimbine PET/neuromelanin MRI study.
Brain : a journal of neurology   03 octobre 2023